Volume is the workflow
Licensing programs are bottlenecked by the cost of qualifying targets. A target screen that takes a paralegal and an associate a week per patent is a target screen that closes off most of the portfolio.
PatentFlare flips that. Once you have public product documentation for a candidate target, a complete evidence of use chart runs in minutes. The unit economics change. A licensing manager can run a chart against a candidate target before deciding whether the engagement is worth attorney hours.
Evidence the licensee can verify
The first question from any sophisticated licensee is where the evidence comes from and whether it actually says what the chart claims. Generic AI tools fail this test immediately. Their citations look plausible and frequently do not exist in the source.
PatentFlare extracts evidence verbatim and validates every quote against the source text. Quotes that cannot be validated are discarded. Each cell of the chart names the document, the page, and the exact quote. A licensee can verify any claim in the chart without trusting the tool that produced it.
A second pass that catches inflation
One of the failure modes that erodes credibility in licensing charts is overreaching. Evidence of a component is read as evidence of a different structural element. Evidence of a technology is read as evidence of a specific claimed mechanism. The chart looks strong until counsel for the target finds the gap.
PatentFlare runs an audit step on every disclosed finding. The chart you send to the target reflects only direct disclosure; inferential readings are marked accordingly, so the chart is already pressure-tested against the kinds of pushback licensees use.
Pay-per-chart, not per seat
Most claim chart software is sold as a seat license at thousands per user per year. That model works for litigation departments running a handful of charts a quarter. It does not work for licensing programs that need to qualify dozens of targets a quarter across patents owned by different entities in the portfolio.
PatentFlare is pay-per-chart. Your first chart is free. After that, charts are $129 each with no subscription. Volume pricing is available for programs running ten or more charts per month. There is no seat license, no per-attorney pricing, and no procurement cycle blocking each new chart.
What it does not replace
Licensing strategy, target prioritization, and the legal judgment on infringement remain with counsel and the licensing team. PatentFlare produces a verifiable evidence of use chart. The decision to assert is yours.
The system does not currently produce invalidity charts. If a target responds to your evidence of use with a prior art defense, you will still need a separate workflow for the invalidity analysis.